BNP PARIBAS FINANCIAL MARKETS - TETRAPHASE PHARMACEUTICALS I ownership

TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 68 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of TETRAPHASE PHARMACEUTICALS I
ValueSharesWeighting
Q2 2019$3,572,000
-77.9%
7,438
-38.4%
0.00%
Q1 2019$16,168,000
+404.1%
12,066
+325.2%
0.00%
Q4 2018$3,207,000
-37.5%
2,838
+52.7%
0.00%
Q3 2018$5,131,000
-22.7%
1,8590.0%0.00%
Q2 2018$6,637,000
-81.1%
1,859
-83.7%
0.00%
Q1 2018$35,084,000
-49.3%
11,428
+4.0%
0.00%
Q4 2017$69,231,000
+189.4%
10,989
+214.2%
0.00%
Q3 2017$23,926,000
-10.4%
3,498
-6.6%
0.00%
Q2 2017$26,716,000
+3130.5%
3,747
+4063.3%
0.00%
Q1 2017$827,000
-51.5%
90
-78.7%
0.00%
Q4 2016$1,705,000
-81.9%
423
-82.8%
0.00%
Q3 2016$9,399,000
+53.8%
2,454
+72.7%
0.00%
Q2 2016$6,110,000
-91.5%
1,421
-80.2%
0.00%
Q4 2015$71,956,000
+27.6%
7,174
-5.1%
0.00%
Q3 2015$56,390,000
-61.0%
7,559
+148.0%
0.00%
Q2 2015$144,597,000
+537.6%
3,048
+392.4%
0.00%
Q1 2015$22,680,000
-13.9%
619
-53.1%
0.00%
Q3 2014$26,354,000
+734.8%
1,321
+464.5%
0.00%
Q2 2014$3,157,000
+57.8%
234
+58.1%
0.00%
Q4 2013$2,001,0001480.00%
Other shareholders
TETRAPHASE PHARMACEUTICALS I shareholders Q2 2019
NameSharesValueWeighting ↓
HARVEY CAPITAL MANAGEMENT INC 293,675$14,061,0004.76%
BB BIOTECH AG 1,507,114$71,497,0001.94%
SECTORAL ASSET MANAGEMENT INC 893,076$42,368,0001.77%
Opaleye Management Inc. 65,000$3,084,0001.23%
COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT 390,294$18,515,0001.14%
Granite Point Capital Management, L.P. 75,206$3,568,0001.04%
Granahan Investment Management 705,601$33,474,0000.95%
Iguana Healthcare Management, LLC 50,000$2,372,0000.75%
Eventide Asset Management 290,000$13,758,0000.74%
Rhenman & Partners Asset Management AB 107,400$5,095,0000.61%
View complete list of TETRAPHASE PHARMACEUTICALS I shareholders